Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 126

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 126
---
 than Kaken or any of its affiliates) any                                                                                                                                                                                                                                                                                                                                          
 non-public information relating to Aadi or Aadi Sub or afford to any third person (other than Kaken or any of its affiliates) access to the business, properties, assets, books, records or other non-public information, or to any personnel, of Aadi or Aadi Sub, in any such case in connection with any actual or potential acquisition inquiry or acquisition proposal or with the intent to induce the making, 
 submission or announcement of, or to knowingly encourage, facilitate or assist, any acquisition inquiry or acquisition proposal;                                                                                                                                                                                                                                                                                     |

| • |     | participate or engage in discussions or negotiations with any third person (other than Kaken or any of its 
 affiliates) with respect to an acquisition inquiry or acquisition proposal;                                |

| • |     | authorize or commit to do any of the foregoing. |

Under and subject to the terms of the Divestiture Agreement, from the date of the Divestiture Agreement until Aadi receives the requisite stockholder approval, Aadi and Aadi Sub may, directly or indirectly through one or more of their representatives (1) participate or engage in discussions or negotiations with, and (2) subject to an Acceptable Confidentiality Agreement, (i) furnish any non-publicinformation relating to Aadi or any of its subsidiaries, and (ii) afford access to the business, properties, assets, books, records or other non-publicinformation, or any personnel, of Aadi or any of its subsidiaries to any person or group or their respective representatives that has made, renewed or delivered to Aadi an acquisition proposal after the date of the Divestiture Agreement that was not solicited in material breach of the applicable restrictions, provided that Aadi has agreed to promptly make available to Kaken and its representatives any non-public information concerning Aadi and its subsidiaries that is made available to any such person or group or their respective representatives and that was not previously made available to Kaken. Aadi’s board of directors may only take the foregoing actions if Aadi’s board of directors has determined in good faith (after consultation with its financial advisor and outside legal counsel) that (1) such acquisition proposal either constitutes a Superior Proposal or is reasonably likely to lead a Superior Proposal, and (2) the failure to take such actions could reasonably be expected to be inconsistent with its fiduciary duties. From the date of the Divestiture Agreement until the earlier to occur of the completion of the Divestiture and the termination of the